Literature DB >> 2569063

Intercontinental spread of an epidemic group A Neisseria meningitidis strain.

P S Moore1, M W Reeves, B Schwartz, B G Gellin, C V Broome.   

Abstract

Electrophoretic enzyme typing revealed that a single group A Neisseria meningitidis clonal complex, designated III-1, was responsible for recent epidemics in Nepal, Saudi Arabia, and Chad. Epidemiological investigations and enzyme typing profiles indicated that this clone was brought from South Asia to the Middle East by Muslims making their pilgrimage (haj) to Mecca, Saudi Arabia, in 1987. Pilgrims who became group A carriers introduced this clonal group into sub-Saharan Africa on their return from the haj. The introduction of this clonal group into sub-Saharan Africa may be responsible for the current wave of epidemics affecting the region. Although the findings suggest that clonal virulence is an important factor in the development of epidemics of meningococcal disease, other factors also seem to be necessary for the development of an epidemic.

Entities:  

Mesh:

Year:  1989        PMID: 2569063     DOI: 10.1016/s0140-6736(89)90439-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  42 in total

1.  The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitidis strains.

Authors:  P Nicolas; G Raphenon; M Guibourdenche; L Decousset; R Stor; A B Gaye
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage.

Authors:  P Mölling; A Bäckman; P Olcén; H Fredlund
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

Review 4.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Characterization of Neisseria meningitidis isolated by ribosomal RNA gene restriction patterns and restriction endonuclease digestion of chromosomal DNA.

Authors:  J Z Jordens; T H Pennington
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

7.  Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern.

Authors:  J Y Riou; D A Caugant; R K Selander; J T Poolman; M Guibourdenche; E Collatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-05       Impact factor: 3.267

8.  Multilocus enzyme electrophoresis - Application to the study of meningococcal meningitis and listeriosis.

Authors:  F Ashton
Journal:  Can J Infect Dis       Date:  1990

Review 9.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

10.  Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.

Authors:  Ana Paula S Lemos; Lee H Harrison; Melina Lenser; Claudio T Sacchi
Journal:  J Infect       Date:  2010-01-06       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.